P91 Antimicrobial activity of ceftolozane/tazobactam and comparators against clinical Gram-negative bacilli collected in the UK: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020–24

2026-06-26

M Wise

M Allen

F Siddiqui

K Young

M Motyl

D Sahm

DOI：10.1093/jacamr/dlag102.097

Original

Original request for help

Save

Abstract

En 中文

Ceftolozane/tazobactam (C/T) is an antipseudomonal cephalosporin combined with a β-lactamase inhibitor approved by the MHRA, EMA and FDA for complicated urinary tract and intraabdominal infections in adults and children, and hospital-acquired/ventilator-associated bacterial pneumonia in adults. We evaluated the activity of C/T against isolates of Enterobacterales and Pseudomonas aeruginosa collected in the UK as part of the global SMART surveillance programme.

P91 Antimicrobial activity of ceftolozane/tazobactam and comparators against clinical Gram-negative bacilli collected in the UK: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2020–24

Abstract

Journal

Organization